Skip to content

B-Thalasaemia Trait and Its Possible Cardioprotective Role

B-Thalasaemia Trait and Its Possible Cardioprotective Role

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02428023
Enrollment
2500
Registered
2015-04-28
Start date
2015-03-31
Completion date
2017-04-30
Last updated
2016-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Beta-Thalassemia Trait, Coronary Artery Disease

Keywords

Thalassemia, trait, coronary, stroke

Brief summary

Our purpose is to investigate whether thallasaemia trait offers protection against cardiovascular events and whether this can be applied to specific characteristics of these people ( better lipid profile , better blood pressure profile) as scientific literature suggests.

Detailed description

Thallasaemia is a major problem , especially in countries around the Mediterranean sea.On the other hand ,thallasaemia trait has been shown ,in a small number of studies , to have a possible protective role against CAD and stroke.These kind of studies have been contacted in Greece also ,and usually they enroll a small number of participants. In the study, investigators will enroll 2500 subjects who serve in military units in Thesally Greece. Firstly investigators will estimate the prevalence of thallasaemia trait in this population , as it is very high in this region and at the same time investigators will retrospectively record data from their personal files (which are annually recorded).

Interventions

None listed

Sponsors

404 General Military Hospital, Larissa
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 57 Years
Healthy volunteers
Yes

Inclusion criteria

1. voluntary participation, 2. Subjects with Thalassemia treat will be confirmed of their treat by electrophoresis -

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frameDescription
Cardioprotective role of Thalassemia Treat1 YEARCardioprotective role of Thalassemia Treat

Countries

Greece

Contacts

Primary ContactElias Andreanidis, PhD
elandreanides@gmail.com+3 6944570406
Backup ContactMaria Malliarou, PhD
mmalliarou@gmail.com+3 6944796499

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026